FDA addresses lack of diversity in clinical trials in draft guidance

June 21, 2019

As seen on Outsourcing-Pharma.com - Posted June 21, 2019 - Original Article

 | By Melissa Fassbender | In a bid to increase clinical trial diversity, the FDA published a draft guidance suggesting sponsors rethink exclusion criteria, include children in adult studies when appropriate, use adaptive trials, and make sure other logistical barriers to participation are addressed.


Continued on Outsourcing Pharma

Previous Article
TrialScope Turns to NOL Program, Venture Fund Investment
TrialScope Turns to NOL Program, Venture Fund Investment

Resources from the NJEDA, three venture capital firms and proximity to pharmaceutical giants has helped Tri...

Next Article
A Three-Pronged Approach
A Three-Pronged Approach